﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2024v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2025-11-03T09:36:36-05:00</ReturnTs>
    <TaxPeriodEndDt>2024-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>481041128</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>SWINDOLL JANZEN HAWK &amp; LOYD LLC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>220 W DOUGLAS AVE SUITE 300</AddressLine1Txt>
        <CityNm>WICHITA</CityNm>
        <StateAbbreviationCd>KS</StateAbbreviationCd>
        <ZIPCd>67202</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2024-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>480840415</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>RIORDAN CLINIC INC</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>RIOR</BusinessNameControlTxt>
      <PhoneNum>3166823100</PhoneNum>
      <USAddress>
        <AddressLine1Txt>3100 N HILLSIDE ST</AddressLine1Txt>
        <CityNm>WICHITA</CityNm>
        <StateAbbreviationCd>KS</StateAbbreviationCd>
        <ZIPCd>67219</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>RON HUNNINGHAKE</PersonNm>
      <PersonTitleTxt>SECRETARY</PersonTitleTxt>
      <PhoneNum>3166823100</PhoneNum>
      <SignatureDt>2025-10-31</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>ADAM L GRILLIOT CPAPFS</PreparerPersonNm>
      <PTIN>P00930960</PTIN>
      <PhoneNum>3162655600</PhoneNum>
      <PreparationDt>2025-10-31</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2024</TaxYr>
    <BuildTS>2025-03-06 01:10:19Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="6">
    <IRS990 documentId="RetDoc2" referenceDocumentId="RetDoc5">
      <PrincipalOfficerNm>RON HUNNINGHAKE</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>3100 N HILLSIDE</AddressLine1Txt>
        <CityNm>WICHITA</CityNm>
        <StateAbbreviationCd>KS</StateAbbreviationCd>
        <ZIPCd>67219</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>7472168</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.RIORDANCLINIC.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1975</FormationYr>
      <LegalDomicileStateCd>KS</LegalDomicileStateCd>
      <ActivityOrMissionDesc>TO PROVIDE MEDICAL RESEARCH AND EDUCATION AND TO SERVE IN WAYS THAT IMPROVE ONES WELL-BEING.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>3</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>2</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>40</TotalEmployeeCnt>
      <TotalVolunteersCnt>8</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>640288</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>1105328</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>6042978</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>5021927</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>22194</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>59450</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>584938</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>548976</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>7290398</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>6735681</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>3780165</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>3271694</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>3839573</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>2937868</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>7619738</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>6209562</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>-329340</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>526119</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>3455153</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>3777043</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>1421440</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>1190101</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>2033713</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>2586942</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>TO PROVIDE MEDICAL RESEARCH AND EDUCATION AND TO SERVE IN WAYS THAT STIMULATES AN EPIDEMIC OF HEALTH AMONG THOSE INTERESTED IN IMPROVING THEIR WELL-BEING.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>4026974</ExpenseAmt>
      <RevenueAmt>3334270</RevenueAmt>
      <Desc>RESEARCH: AT THE HEART OF THE RIORDAN CLINIC'S DAY-TO-DAY WORK AND LONG-TERM VISION IS THE RIORDAN CLINIC RESEARCH INSTITUTE. CONSISTING OF A SMALL BUT DEDICATED GROUP OF SCIENTISTS WHO ARE PASSIONATE ABOUT THEIR WORK, THE RIORDAN CLINIC RESEARCH INSTITUTE FOCUSES RESEARCH IN AREAS OF NUTRITIONAL MEDICINE AND NATURAL THERAPEUTICS. BECAUSE OF THE CLOSE RELATIONSHIP BETWEEN OUR RESEARCH TEAM AND THE PHYSICIANS AT THE RIORDAN CLINIC, WE ARE ABLE TO TARGET OUR RESEARCH TOWARD INNOVATIONS THAT WILL BE DIRECTLY BENEFICIAL TO RIORDAN CLINIC PATIENTS. THE RCRI OPERATES INDEPENDENTLY OF SPECIAL INTERESTS: IT NEITHER SOLICITS NOR ACCEPTS TAX-DERIVED FUNDS. ALL OF ITS RESEARCH FUNDING COMES FROM PRIVATE DONATIONS FROM INDIVIDUALS,CORPORATIONS, AND FOUNDATIONS. RESULTS OF THE RCRI'S RESEARCH ARE PRESENTED DURING LECTURES AND AT THE CONFERENCES, PUBLISHED IN PEER- REVIEWED JOURNALS, AND DESCRIBED ON THE CLINICS'S WEBSITE. THE RIORDAN CLINIC RESEARCH INSTITUTE WORKS TO DEVELOP NUTRIENT-BASED THERAPIES THAT RESOLVE PATHOLOGY WITHOUT HARMING NORMAL TISSUES. WE HAVE LONG BEEN A LEADER IN RESEARCH CONCERNING THE USE OF VITAMIN C IN CANCER THERAPY, AND HAVE EXTENSIVE EXPERIENCE IN DEVELOPING ALTERNATIVE THERAPIES FOR CANCER. OUR RESEARCH IN 2022 FOCUSED ON THE FOLLOWING AREAS (A MORE IN DEPTH REPORT IS AVAILABLE BY REQUEST): -EFFECTS OF MICRONUTRIENT SUPPLEMENTATION ON CONCENTRATIONS OF VITAMINS AND MINERALS, INFLAMMATION AND CARDIOVASCULAR RISK. -EFFECT OF HIGH DOSE VITAMIN C ON EPSTEIN-BARR VIRAL INFECTION. -THE RIORDAN CLINIC INTRAVENOUS VITAMIN C PROTOCOL AND BACKGROUND RESEARCH. -THE ROLE OF MITOCHONDRIA IN CANCER AND OTHER CHRONIC DISEASES. BIOENERGETICS OF HUMAN CANCER CELLS AND NORMAL CELLS DURING PROLIFERATION AND DIFFERENTIATION. -MODULATION OF CYTOKINES IN CANCER PATIENTS BY INTRAVENOUS ASCORBATE THERAPY. -BACTERIAL EXTRACTS: BIOLOGICAL RESPONSE MODIFIERS BASED ON BACTERIAL CELL WALL CARBOHYDRATES. CLINIC: AT RIORDAN CLINIC, WE WORK WITH YOU, AS A CO-LEARNER, TO RESTORE, IMPROVE, OR MAINTAIN YOUR HEALTH. WE BELIEVE IN REAL HEALTH, AND BY UNDERSTANDING YOUR INDIVIDUAL BIOCHEMICAL MAKE-UP WE ARE ABLE TO CREATE A UNIQUE HEALTH PATH FOR YOU. WE FOCUS ON NUTRITION THROUGH NUTRIENT TESTING AND WE ARE DEDICATED TO RESEARCH. THROUGH TESTING, THERAPIES, SERVICES AND NUTRIENTS WE WILL INDIVIDUALIZE A JOURNEY TO ENSURE THAT YOU FEEL YOUR ABSOLUTE BEST. THE RIORDAN CLINIC HAS CARED FOR INDIVIDUALS WITH A FOCUS ON HEALTH, RATHER THAN SICKNESS. WE BELIEVE IN THE IMPORTANCE OF LOOKING AT THE ROOT CAUSE OF ILLNESS, RATHER THAN TREATING SYMPTOMS. WE SUCCESSFULLY TREAT A WIDE VARIETY OF SUSTAINED ILLNESSES INCLUDING, BUT NOT LIMITED TO: CANCER, HEART DISEASE, CHRONIC FATIGUE SYNDROME, FIBROMYALGIA, AND DIABETES. SOME OF OUR MOST ENCOURAGING SUCCESS STORIES ARE WITH PATIENTS WHO HAVE A VARIETY OF LONG-TERM SYMPTOMS, BUT HAVE BEEN UNABLE TO GET A DIAGNOSIS. WE SEEK TO IDENTIFY THE UNDERLYING CAUSES OF ILLNESS AND CORRECT THEM USING NUTRIENT BALANCING AND OTHER THERAPIES. SYMPTOMS LIKE FATIGUE, RASH, CONSTIPATION, STIFFNESS, SWELLING, DEPRESSION, AND MANY OTHERS, ARE THE MANIFESTATION OF AN UNBALANCED CHEMISTRY WITHIN THE BODY. AT THE RIORDAN CLINIC, WE KNOW THAT THE NUTRIENTS IN OUR BODY CONTROL OUR CHEMISTRY, AND IF OUR INVENTORY IS LOW OR IN EXCESS OF SOME NUTRIENTS, SYMPTOMS ARE INEVITABLE. FOR THIS REASON, OUR PATIENTS, CALLED CO-LEARNERS, START WITH A BASELINE NUTRIENT INVENTORY PANEL ORDERED SO THAT THE DOCTORS CAN LEARN MORE ABOUT THEIR INDIVIDUALITY. OUR APPROACH IS TO TREAT THE WHOLE PERSON, BEGINNING WITH A THOROUGH REVIEW OF MEDICAL HISTORY AND A COMPREHENSIVE PATIENT EVALUATION. THIS YIELDS A HIGHLY CUSTOMIZED HOLISTIC TREATMENT PLAN THAT WILL PUT YOU ON THE PATH TO BETTER HEALTH. AS A PATIENT AT THE RIORDAN CLINIC, YOU WILL BE FULLY INVOLVED IN THE DISCOVERY PROCESS OF GETTING WELL. BY TAKING AN ACTIVE ROLE IN YOUR RECOVERY, YOU WILL UNDERSTAND THE SYSTEMIC CAUSES OF YOUR ILLNESS BETTER, THUS ENACTING A POSITIVE IMPACT ON YOUR HEALTH.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>1098496</ExpenseAmt>
        <RevenueAmt>1654845</RevenueAmt>
        <Desc>LABORATORY: THE ON-SITE RIORDAN CLINIC LABORATORY WAS ESTABLISHED IN 1975, ORIGINALLY AS THE BIO-CENTER LAB. OUR LAB HAS DEDICATED ITSELF TO PROVIDING ACCURATE CLINICAL ANALYSIS FOCUSING ON NUTRITIONAL LEVELS. OUR SPECIALTIES INCLUDE TESTING FOR PYRROLES, HISTAMINE, CYTOTOXIC FOOD SENSITIVITIES, PARASITOLOGY, ANALYSIS OF RED BLOOD CELL FATTY ACIDS AND MINERALS, ALONG WITH MANY VITAMINS. WE HAVE DONE EXHAUSTIVE RESEARCH TO DETERMINE WHICH TEST METHODOLOGIES AND SPECIMEN TYPES WILL YIELD THE MOST CLINICALLY SIGNIFICANT RESULTS. WE HAVE BEEN PERFORMING AND INNOVATING MANY OF OUR SPECIALTY TESTS FOR MORE THAN 30 YEARS. OUR HISTAMINE AND PYRROLES TESTS HAVE BEEN OFFERED FOR 38 YEARS AND ARE STILL TWO OF THE MOST REQUESTED REFERENCE TESTS WE PERFORM. IN FACT, WE ARE PROUD TO BE THE LABORATORY THAT MANY OTHER LABS CHOOSE TO DO THEIR PYRROLES TESTING. THE FUNCTION OF OUR LABORATORY IS TWO-FOLD: TO PROVIDE IN-HOUSE PATIENTS WHO COME FOR TREATMENT WITH ACCURATE STATE OF THE ART LABORATORY ANALYSIS AND TO PROVIDE DIAGNOSTIC SERVICES FOR PHYSICIANS AND HOSPITALS THROUGHOUT THE COUNTRY. IN BOTH CASES, WE PROVIDE DOCTORS RELEVANT BIOCHEMICAL IMPAIRMENT INFORMATON TO INCREASE DIAGNOSTIC ACCURACY.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <ExpenseAmt>46269</ExpenseAmt>
        <RevenueAmt>32812</RevenueAmt>
        <Desc>EDUCATION: THE RIORDAN CLINIC HAS A VARIETY OF EVENTS FROM OUR BI-ANNUAL IVC &amp; CANCER SYMPOSIUMS TO LUNCH AND LECTURES. OUR APPROACH IS ONE OF INTEGRATIVE MEDICINE, WHERE WE MAXIMIZE THE BENEFITS OF BOTH ORTHOMOLECULAR AND CONVENTIONAL MEDICINE TO ACHIEVE RESULTS. SINCE CO-LEARNERS AT THE RIORDAN CLINIC HAVE A VESTED INTEREST IN THE RESEARCH AND DISCOVERY PROCESS, THEY ATTAIN THE ULTIMATE FORM OF HEALING: HOPE. THE RIORDAN CLINIC SYMPOSIUM (HELD BI-ANNUALLY, THE NEXT IS SCHEDULED FOR FALL 2023) EXPLORES THE UNDERLYING CAUSES OF CANCER, WITH THE INTENT OF ELUCIDATING NEW WAYS TO TREAT THE DISEASE IN A NON-TOXIC FASHION. ACADEMY SPEAKERS REPRESENT A GROWING FIELD OF CANCER PIONEERS WHO HAVE FOUND THAT IVC IS A POWERFUL ADJUNCT IN THE CARE OF CANCER PATIENTS. ALTHOUGH INTENDED FOR MEDICAL PROFESSIONALS, THE LECTURES ALSO SERVE TO INFORM INTERESTED "CANCER CO- LEARNERS" WHO SEEK HELP FOR THEMSELVES AND THEIR FRIENDS AND FAMILY THROUGH A BETTER QUALITY OF LIFE. THE RIORDAN CLINIC IVC ACADEMY IS PACKED WITH TWO DAYS OF LECTURES, CONVERSATIONS, AND CAMARADERIE WITH OTHER MEDICAL PROFESSIONALS WHO USE HIGH-DOSE VITAMIN C IN THEIR PRACTICES. ON FRIDAY THERE WILL BE MULTIPLE SPEAKERS LAYING OUT THE HISTORY AND STEPS BEHIND THE PROPER USE OF THE RIORDAN IVC PROTOCOL. THE ACADEMY LECTURES WILL SERVE AS AN EXCELLENT OPPORTUNITY FOR IVC PRACTITIONERS TO BECOME MORE INVOLVED WITH IVC THERAPY, ADJUNCT THERAPIES AND EXPOUND NEW APPROACHES TO TREATING CANCER. LECTURES CONTINUE INTO SATUDAY AND WE WILL CONCLUDE THE EVENT WITH THE RIORDAN IVC CERTIFICATION TEST, WHICH WILL BE GRADED AND RETURNED BEFORE DISMISSAL. THE RIORDAN RESOURCE LIBRARY ORIGINALLY FUNDED BY THE MABEE FAMILY, PROVIDES COMPREHENSIVE INFORMATION ABOUT THE HUMAN CONDITION. THE LIBRARY IS AVAILABLE TO ANYONE WHO WISHES TO EXPAND THEIR KNOWLEDGE ON A PARTICULAR MEDICAL SUBJECT. SOME OF THE RESOURCES AVAILABLE TO ASSIST YOU IN YOUR RESEARCH INCLUDE MORE THAN 3,000 BOOKS, 1,200 VIDEOS AND 3,200 AUDIO TAPES. ADDITIONALLY, OUR JOURNAL ARTICLE COLLECTION CONTINUES TO GROW AS NEW RESEARCH IN VARIOUS FIELDS BREAKS TO THE SURFACE. MORE THAN 10,000 ARTICLES HAVE BEEN COLLECTED FROM SOURCES OUTSIDE OUR LIBRARY. AS A RESEARCH LIBRARY, YOU'RE WELCOME TO UTILIZE OUR COLLECTION SOLEY ON SITE. SUPPLEMENT YOUR RESEARCH AND FINDINGS WITH INTERNET ACCESS. THE MAYBEE LIBRARY WILL CONTINUE TO BE CUTTING EDGE BASED ON PRIVATE DONATIONS FROM INDIVIDUALS, CORPORATIONS, AND FOUNDATIONS. SINCE CO-LEARNERS ARE ENCOURAGED TO SEEK OUT INFORMATION ABOUT THEIR INDIVIDUAL NEEDS, THE RIORDAN RESOURCE LIBRARY PLAYS A SIGNIFICANT ROLE IN THAT PROCESS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>5171739</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc6">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc3">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc3">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc3">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc3">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc3">true</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc3">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc3">true</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc3">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc3">true</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc3">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc3">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc3">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc3">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc4">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>12</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>40</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>3</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>2</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>false</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>false</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>false</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>true</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>KIMBERLY DAY</PersonNm>
        <PhoneNum>3166823100</PhoneNum>
        <USAddress>
          <AddressLine1Txt>3100 N HILLSIDE</AddressLine1Txt>
          <CityNm>WICHITA</CityNm>
          <StateAbbreviationCd>KS</StateAbbreviationCd>
          <ZIPCd>67219</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>RON HUNNINGHAKE</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>183000</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>VERNE HARNISH</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>THOMAS LEVY MD</PersonNm>
        <TitleTxt>BOARD MEMBER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MICHAEL STEWART</PersonNm>
        <TitleTxt>CEO</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>183000</TotalReportableCompFromOrgAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <AllOtherContributionsAmt>1105328</AllOtherContributionsAmt>
      <TotalContributionsAmt>1105328</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PATIENT FEES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>3772281</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3772281</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>MEDICAL SUPPLIES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>1128571</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1128571</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>LAB SERVICES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>106175</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>106175</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>DOCTOR SHADOWING FEES</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>14900</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>14900</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>5021927</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>36250</TotalRevenueColumnAmt>
        <ExclusionAmt>36250</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>139456</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>116256</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>23200</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>23200</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>23200</RelatedOrExemptFuncIncomeAmt>
      </NetGainOrLossInvestmentsGrp>
      <GrossSalesOfInventoryAmt>1164074</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>620231</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>543843</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>543843</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>HONORARIUMS AND SYMPOSIUMS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>4099</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>4099</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalRevenueColumnAmt>1034</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1034</RelatedOrExemptFuncIncomeAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>5133</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>6735681</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5594103</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>36250</ExclusionAmt>
      </TotalRevenueGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>183000</TotalAmt>
        <ManagementAndGeneralAmt>183000</ManagementAndGeneralAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>2594514</TotalAmt>
        <ProgramServicesAmt>2266023</ProgramServicesAmt>
        <ManagementAndGeneralAmt>328491</ManagementAndGeneralAmt>
      </OtherSalariesAndWagesGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>286808</TotalAmt>
        <ProgramServicesAmt>247617</ProgramServicesAmt>
        <ManagementAndGeneralAmt>39191</ManagementAndGeneralAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>207372</TotalAmt>
        <ProgramServicesAmt>168067</ProgramServicesAmt>
        <ManagementAndGeneralAmt>39305</ManagementAndGeneralAmt>
      </PayrollTaxesGrp>
      <FeesForServicesLegalGrp>
        <TotalAmt>21562</TotalAmt>
        <ManagementAndGeneralAmt>21562</ManagementAndGeneralAmt>
      </FeesForServicesLegalGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>124278</TotalAmt>
        <ProgramServicesAmt>11618</ProgramServicesAmt>
        <ManagementAndGeneralAmt>112660</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>62145</TotalAmt>
        <ProgramServicesAmt>62145</ProgramServicesAmt>
      </FeesForServicesOtherGrp>
      <AdvertisingGrp>
        <TotalAmt>76395</TotalAmt>
        <ProgramServicesAmt>42277</ProgramServicesAmt>
        <ManagementAndGeneralAmt>34118</ManagementAndGeneralAmt>
      </AdvertisingGrp>
      <OfficeExpensesGrp>
        <TotalAmt>53768</TotalAmt>
        <ProgramServicesAmt>40678</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13090</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>373491</TotalAmt>
        <ProgramServicesAmt>291971</ProgramServicesAmt>
        <ManagementAndGeneralAmt>81520</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>42525</TotalAmt>
        <ProgramServicesAmt>40064</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2461</ManagementAndGeneralAmt>
      </TravelGrp>
      <InterestGrp>
        <TotalAmt>10295</TotalAmt>
        <ProgramServicesAmt>10295</ProgramServicesAmt>
      </InterestGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>128358</TotalAmt>
        <ProgramServicesAmt>114626</ProgramServicesAmt>
        <ManagementAndGeneralAmt>13732</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>134839</TotalAmt>
        <ProgramServicesAmt>34246</ProgramServicesAmt>
        <ManagementAndGeneralAmt>100593</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>MEDICAL SUPPLIES</Desc>
        <TotalAmt>922398</TotalAmt>
        <ProgramServicesAmt>922398</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>OUTSIDE LAB TESTING</Desc>
        <TotalAmt>277720</TotalAmt>
        <ProgramServicesAmt>277720</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SERVICE CHARGES</Desc>
        <TotalAmt>164546</TotalAmt>
        <ProgramServicesAmt>162312</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2234</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CONTRACT LABOR</Desc>
        <TotalAmt>100275</TotalAmt>
        <ProgramServicesAmt>100275</ProgramServicesAmt>
      </OtherExpensesGrp>
      <AllOtherExpensesGrp>
        <TotalAmt>445273</TotalAmt>
        <ProgramServicesAmt>379407</ProgramServicesAmt>
        <ManagementAndGeneralAmt>65866</ManagementAndGeneralAmt>
      </AllOtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>6209562</TotalAmt>
        <ProgramServicesAmt>5171739</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1037823</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>832792</BOYAmt>
        <EOYAmt>680147</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <EOYAmt>506153</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>37907</BOYAmt>
        <EOYAmt>29385</EOYAmt>
      </AccountsReceivableGrp>
      <InventoriesForSaleOrUseGrp>
        <BOYAmt>150663</BOYAmt>
        <EOYAmt>111029</EOYAmt>
      </InventoriesForSaleOrUseGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>38396</BOYAmt>
        <EOYAmt>108605</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>10322256</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>9385156</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>842345</BOYAmt>
        <EOYAmt>937100</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>669348</BOYAmt>
        <EOYAmt>732280</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>883702</BOYAmt>
        <EOYAmt>672344</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>3455153</BOYAmt>
        <EOYAmt>3777043</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>297195</BOYAmt>
        <EOYAmt>327436</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>79271</BOYAmt>
        <EOYAmt>86271</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>1044974</BOYAmt>
        <EOYAmt>776394</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>1421440</BOYAmt>
        <EOYAmt>1190101</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1319305</BOYAmt>
        <EOYAmt>2086942</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>714408</BOYAmt>
        <EOYAmt>500000</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>2033713</BOYAmt>
        <EOYAmt>2586942</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>3455153</BOYAmt>
        <EOYAmt>3777043</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>526119</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>27110</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc6">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus4YearsAmt>573250</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>184155</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>51856</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>640288</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1105328</CurrentTaxYearAmt>
        <TotalAmt>2554877</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>5471362</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>7323031</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>8943215</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>7333538</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>6191134</CurrentTaxYearAmt>
        <TotalAmt>35262280</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>6044612</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>7507186</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>8995071</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>7973826</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>7296462</CurrentTaxYearAmt>
        <TotalAmt>37817157</TotalAmt>
      </Total509Grp>
      <PublicSupportTotal509Amt>37817157</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus4YearsAmt>11164</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>11718</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>14528</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>17815</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>36250</CurrentTaxYearAmt>
        <TotalAmt>91475</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus4YearsAmt>11164</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>11718</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>14528</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>17815</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>36250</CurrentTaxYearAmt>
        <TotalAmt>91475</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>6055776</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>7518904</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>9009599</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>7991641</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>7332712</CurrentTaxYearAmt>
        <TotalAmt>37908632</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.99760</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.99800</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc3">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>622444</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>73098</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>5309</OtherExpendituresAmt>
        <EndYearBalanceAmt>690233</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>537621</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>89457</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4634</OtherExpendituresAmt>
        <EndYearBalanceAmt>622444</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>648419</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>-106276</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4522</OtherExpendituresAmt>
        <EndYearBalanceAmt>537621</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>595918</BeginningYearBalanceAmt>
        <InvestmentEarningsOrLossesAmt>57361</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>4860</OtherExpendituresAmt>
        <EndYearBalanceAmt>648419</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>605598</BeginningYearBalanceAmt>
        <ContributionsAmt>100000</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>87439</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>97119</OtherExpendituresAmt>
        <EndYearBalanceAmt>595918</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.01000</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.72430</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.26570</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>false</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>false</EndowmentsHeldRelatedOrgInd>
      <LandGrp>
        <OtherCostOrOtherBasisAmt>300729</OtherCostOrOtherBasisAmt>
        <BookValueAmt>300729</BookValueAmt>
      </LandGrp>
      <BuildingsGrp>
        <OtherCostOrOtherBasisAmt>4760301</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>4500270</DepreciationAmt>
        <BookValueAmt>260031</BookValueAmt>
      </BuildingsGrp>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>5261226</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>4884886</DepreciationAmt>
        <BookValueAmt>376340</BookValueAmt>
      </EquipmentGrp>
      <TotalBookValueLandBuildingsAmt>937100</TotalBookValueLandBuildingsAmt>
      <OtherSecuritiesGrp>
        <Desc>MARKET EQUITY STOCK &amp; MUTUAL FUNDS</Desc>
        <BookValueAmt>732280</BookValueAmt>
        <MethodValuationCd>F</MethodValuationCd>
      </OtherSecuritiesGrp>
      <TotalBookValueSecuritiesAmt>732280</TotalBookValueSecuritiesAmt>
      <OtherAssetsOrgGrp>
        <Desc>OPERATING LEASE - ROU</Desc>
        <BookValueAmt>542819</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>FINANCE LEASE - ROU</Desc>
        <BookValueAmt>129525</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>672344</TotalBookValueOtherAssetsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>LT PORTION OF OPERATING LEASE</Desc>
        <Amt>381450</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>CURRENT PORTION OF OPERATING LEASE</Desc>
        <Amt>175833</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>LT PORTION OF FINANCE LEASE</Desc>
        <Amt>99897</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>PATIENT CREDITS</Desc>
        <Amt>70665</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>CURRENT PORTION OF FINANCE LEASE</Desc>
        <Amt>33549</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>LINE OF CREDIT</Desc>
        <Amt>15000</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>776394</TotalLiabilityAmt>
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>6762791</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>27110</NetUnrealizedGainsInvstAmt>
      <RevenueNotReportedAmt>27110</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>6735681</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>6735681</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>6209562</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>6209562</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>6209562</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 2, PART V, LINE 4</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S ENDOWMENT FUNDS ARE TO BE USED SOLELY FOR RESEARCH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 3, PART X</FormAndLineReferenceDesc>
        <ExplanationTxt>ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA PROVIDE ACCOUNTING AND DISCLOSURE GUIDANCE ABOUT POSITIONS TAKEN BY AN ENTITY IN ITS TAX RETURNS THAT MAY BE UNCERTAIN. THE CLINIC ACCOUNTS FOR ITS UNCERTAIN TAX POSITIONS IN ACCORDANCE WITH FASB ASC TOPIC 740 ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES (ASC 740), WHICH CLARIFIES THE ACCOUNTING FOR INCOME TAXES BY PRESCRIBING THE MINIMUM RECOGNITION THRESHOLD A TAX POSITION IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE FINANCIAL STATEMENTS AND APPLIES TO ALL TAX POSITIONS RELATED TO INCOME TAXES UNDER ASC 740. MANAGEMENT HAS CONSIDERED ITS TAX POSITIONS AND BELIEVES THAT ALL OF THE POSITIONS TAKEN BY THE CLINIC IN ITS FEDERAL AND STATE EXEMPT ORGANIZATION TAX RETURNS ARE MORE LIKELY THAN NOT TO BE SUSTAINED UPON EXAMINATION. THE CLINIC FILES INCOME TAX RETURNS IN THE U.S. FEDERAL JURISDICTION AND IN APPLICABLE STATE JURISDICTIONS AS MANDATED. THE CLINIC IS NO LONGER SUBJECT TO U.S. FEDERAL, STATE AND LOCAL, OR NON-U.S. INCOME TAX EXAMINATIONS BY TAX AUTHORITIES PRIOR TO 2021.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleJ documentId="RetDoc4">
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>RON HUNNINGHAKE</PersonNm>
        <TitleTxt>SECRETARY</TitleTxt>
        <BaseCompensationFilingOrgAmt>183000</BaseCompensationFilingOrgAmt>
        <TotalCompensationFilingOrgAmt>183000</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc5">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>RESEARCH: AT THE HEART OF THE RIORDAN CLINIC'S DAY-TO-DAY WORK AND LONG-TERM VISION IS THE RIORDAN CLINIC RESEARCH INSTITUTE. CONSISTING OF A SMALL BUT DEDICATED GROUP OF SCIENTISTS WHO ARE PASSIONATE ABOUT THEIR WORK, THE RIORDAN CLINIC RESEARCH INSTITUTE FOCUSES RESEARCH IN AREAS OF NUTRITIONAL MEDICINE AND NATURAL THERAPEUTICS. BECAUSE OF THE CLOSE RELATIONSHIP BETWEEN OUR RESEARCH TEAM AND THE PHYSICIANS AT THE RIORDAN CLINIC, WE ARE ABLE TO TARGET OUR RESEARCH TOWARD INNOVATIONS THAT WILL BE DIRECTLY BENEFICIAL TO RIORDAN CLINIC PATIENTS. THE RCRI OPERATES INDEPENDENTLY OF SPECIAL INTERESTS: IT NEITHER SOLICITS NOR ACCEPTS TAX-DERIVED FUNDS. ALL OF ITS RESEARCH FUNDING COMES FROM PRIVATE DONATIONS FROM INDIVIDUALS,CORPORATIONS, AND FOUNDATIONS. RESULTS OF THE RCRI'S RESEARCH ARE PRESENTED DURING LECTURES AND AT THE CONFERENCES, PUBLISHED IN PEER- REVIEWED JOURNALS, AND DESCRIBED ON THE CLINICS'S WEBSITE. THE RIORDAN CLINIC RESEARCH INSTITUTE WORKS TO DEVELOP NUTRIENT-BASED THERAPIES THAT RESOLVE PATHOLOGY WITHOUT HARMING NORMAL TISSUES. WE HAVE LONG BEEN A LEADER IN RESEARCH CONCERNING THE USE OF VITAMIN C IN CANCER THERAPY, AND HAVE EXTENSIVE EXPERIENCE IN DEVELOPING ALTERNATIVE THERAPIES FOR CANCER. OUR RESEARCH IN 2022 FOCUSED ON THE FOLLOWING AREAS (A MORE IN DEPTH REPORT IS AVAILABLE BY REQUEST): -EFFECTS OF MICRONUTRIENT SUPPLEMENTATION ON CONCENTRATIONS OF VITAMINS AND MINERALS, INFLAMMATION AND CARDIOVASCULAR RISK. -EFFECT OF HIGH DOSE VITAMIN C ON EPSTEIN-BARR VIRAL INFECTION. -THE RIORDAN CLINIC INTRAVENOUS VITAMIN C PROTOCOL AND BACKGROUND RESEARCH. -THE ROLE OF MITOCHONDRIA IN CANCER AND OTHER CHRONIC DISEASES. BIOENERGETICS OF HUMAN CANCER CELLS AND NORMAL CELLS DURING PROLIFERATION AND DIFFERENTIATION. -MODULATION OF CYTOKINES IN CANCER PATIENTS BY INTRAVENOUS ASCORBATE THERAPY. -BACTERIAL EXTRACTS: BIOLOGICAL RESPONSE MODIFIERS BASED ON BACTERIAL CELL WALL CARBOHYDRATES. CLINIC: AT RIORDAN CLINIC, WE WORK WITH YOU, AS A CO-LEARNER, TO RESTORE, IMPROVE, OR MAINTAIN YOUR HEALTH. WE BELIEVE IN REAL HEALTH, AND BY UNDERSTANDING YOUR INDIVIDUAL BIOCHEMICAL MAKE-UP WE ARE ABLE TO CREATE A UNIQUE HEALTH PATH FOR YOU. WE FOCUS ON NUTRITION THROUGH NUTRIENT TESTING AND WE ARE DEDICATED TO RESEARCH. THROUGH TESTING, THERAPIES, SERVICES AND NUTRIENTS WE WILL INDIVIDUALIZE A JOURNEY TO ENSURE THAT YOU FEEL YOUR ABSOLUTE BEST. THE RIORDAN CLINIC HAS CARED FOR INDIVIDUALS WITH A FOCUS ON HEALTH, RATHER THAN SICKNESS. WE BELIEVE IN THE IMPORTANCE OF LOOKING AT THE ROOT CAUSE OF ILLNESS, RATHER THAN TREATING SYMPTOMS. WE SUCCESSFULLY TREAT A WIDE VARIETY OF SUSTAINED ILLNESSES INCLUDING, BUT NOT LIMITED TO: CANCER, HEART DISEASE, CHRONIC FATIGUE SYNDROME, FIBROMYALGIA, AND DIABETES. SOME OF OUR MOST ENCOURAGING SUCCESS STORIES ARE WITH PATIENTS WHO HAVE A VARIETY OF LONG-TERM SYMPTOMS, BUT HAVE BEEN UNABLE TO GET A DIAGNOSIS. WE SEEK TO IDENTIFY THE UNDERLYING CAUSES OF ILLNESS AND CORRECT THEM USING NUTRIENT BALANCING AND OTHER THERAPIES. SYMPTOMS LIKE FATIGUE, RASH, CONSTIPATION, STIFFNESS, SWELLING, DEPRESSION, AND MANY OTHERS, ARE THE MANIFESTATION OF AN UNBALANCED CHEMISTRY WITHIN THE BODY. AT THE RIORDAN CLINIC, WE KNOW THAT THE NUTRIENTS IN OUR BODY CONTROL OUR CHEMISTRY, AND IF OUR INVENTORY IS LOW OR IN EXCESS OF SOME NUTRIENTS, SYMPTOMS ARE INEVITABLE. FOR THIS REASON, OUR PATIENTS, CALLED CO-LEARNERS, START WITH A BASELINE NUTRIENT INVENTORY PANEL ORDERED SO THAT THE DOCTORS CAN LEARN MORE ABOUT THEIR INDIVIDUALITY. OUR APPROACH IS TO TREAT THE WHOLE PERSON, BEGINNING WITH A THOROUGH REVIEW OF MEDICAL HISTORY AND A COMPREHENSIVE PATIENT EVALUATION. THIS YIELDS A HIGHLY CUSTOMIZED HOLISTIC TREATMENT PLAN THAT WILL PUT YOU ON THE PATH TO BETTER HEALTH. AS A PATIENT AT THE RIORDAN CLINIC, YOU WILL BE FULLY INVOLVED IN THE DISCOVERY PROCESS OF GETTING WELL. BY TAKING AN ACTIVE ROLE IN YOUR RECOVERY, YOU WILL UNDERSTAND THE SYSTEMIC CAUSES OF YOUR ILLNESS BETTER, THUS ENACTING A POSITIVE IMPACT ON YOUR HEALTH.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>LABORATORY: THE ON-SITE RIORDAN CLINIC LABORATORY WAS ESTABLISHED IN 1975, ORIGINALLY AS THE BIO-CENTER LAB. OUR LAB HAS DEDICATED ITSELF TO PROVIDING ACCURATE CLINICAL ANALYSIS FOCUSING ON NUTRITIONAL LEVELS. OUR SPECIALTIES INCLUDE TESTING FOR PYRROLES, HISTAMINE, CYTOTOXIC FOOD SENSITIVITIES, PARASITOLOGY, ANALYSIS OF RED BLOOD CELL FATTY ACIDS AND MINERALS, ALONG WITH MANY VITAMINS. WE HAVE DONE EXHAUSTIVE RESEARCH TO DETERMINE WHICH TEST METHODOLOGIES AND SPECIMEN TYPES WILL YIELD THE MOST CLINICALLY SIGNIFICANT RESULTS. WE HAVE BEEN PERFORMING AND INNOVATING MANY OF OUR SPECIALTY TESTS FOR MORE THAN 30 YEARS. OUR HISTAMINE AND PYRROLES TESTS HAVE BEEN OFFERED FOR 38 YEARS AND ARE STILL TWO OF THE MOST REQUESTED REFERENCE TESTS WE PERFORM. IN FACT, WE ARE PROUD TO BE THE LABORATORY THAT MANY OTHER LABS CHOOSE TO DO THEIR PYRROLES TESTING. THE FUNCTION OF OUR LABORATORY IS TWO-FOLD: TO PROVIDE IN-HOUSE PATIENTS WHO COME FOR TREATMENT WITH ACCURATE STATE OF THE ART LABORATORY ANALYSIS AND TO PROVIDE DIAGNOSTIC SERVICES FOR PHYSICIANS AND HOSPITALS THROUGHOUT THE COUNTRY. IN BOTH CASES, WE PROVIDE DOCTORS RELEVANT BIOCHEMICAL IMPAIRMENT INFORMATON TO INCREASE DIAGNOSTIC ACCURACY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4C</FormAndLineReferenceDesc>
        <ExplanationTxt>EDUCATION: THE RIORDAN CLINIC HAS A VARIETY OF EVENTS FROM OUR BI-ANNUAL IVC &amp; CANCER SYMPOSIUMS TO LUNCH AND LECTURES. OUR APPROACH IS ONE OF INTEGRATIVE MEDICINE, WHERE WE MAXIMIZE THE BENEFITS OF BOTH ORTHOMOLECULAR AND CONVENTIONAL MEDICINE TO ACHIEVE RESULTS. SINCE CO-LEARNERS AT THE RIORDAN CLINIC HAVE A VESTED INTEREST IN THE RESEARCH AND DISCOVERY PROCESS, THEY ATTAIN THE ULTIMATE FORM OF HEALING: HOPE. THE RIORDAN CLINIC SYMPOSIUM (HELD BI-ANNUALLY, THE NEXT IS SCHEDULED FOR FALL 2023) EXPLORES THE UNDERLYING CAUSES OF CANCER, WITH THE INTENT OF ELUCIDATING NEW WAYS TO TREAT THE DISEASE IN A NON-TOXIC FASHION. ACADEMY SPEAKERS REPRESENT A GROWING FIELD OF CANCER PIONEERS WHO HAVE FOUND THAT IVC IS A POWERFUL ADJUNCT IN THE CARE OF CANCER PATIENTS. ALTHOUGH INTENDED FOR MEDICAL PROFESSIONALS, THE LECTURES ALSO SERVE TO INFORM INTERESTED "CANCER CO- LEARNERS" WHO SEEK HELP FOR THEMSELVES AND THEIR FRIENDS AND FAMILY THROUGH A BETTER QUALITY OF LIFE. THE RIORDAN CLINIC IVC ACADEMY IS PACKED WITH TWO DAYS OF LECTURES, CONVERSATIONS, AND CAMARADERIE WITH OTHER MEDICAL PROFESSIONALS WHO USE HIGH-DOSE VITAMIN C IN THEIR PRACTICES. ON FRIDAY THERE WILL BE MULTIPLE SPEAKERS LAYING OUT THE HISTORY AND STEPS BEHIND THE PROPER USE OF THE RIORDAN IVC PROTOCOL. THE ACADEMY LECTURES WILL SERVE AS AN EXCELLENT OPPORTUNITY FOR IVC PRACTITIONERS TO BECOME MORE INVOLVED WITH IVC THERAPY, ADJUNCT THERAPIES AND EXPOUND NEW APPROACHES TO TREATING CANCER. LECTURES CONTINUE INTO SATUDAY AND WE WILL CONCLUDE THE EVENT WITH THE RIORDAN IVC CERTIFICATION TEST, WHICH WILL BE GRADED AND RETURNED BEFORE DISMISSAL. THE RIORDAN RESOURCE LIBRARY ORIGINALLY FUNDED BY THE MABEE FAMILY, PROVIDES COMPREHENSIVE INFORMATION ABOUT THE HUMAN CONDITION. THE LIBRARY IS AVAILABLE TO ANYONE WHO WISHES TO EXPAND THEIR KNOWLEDGE ON A PARTICULAR MEDICAL SUBJECT. SOME OF THE RESOURCES AVAILABLE TO ASSIST YOU IN YOUR RESEARCH INCLUDE MORE THAN 3,000 BOOKS, 1,200 VIDEOS AND 3,200 AUDIO TAPES. ADDITIONALLY, OUR JOURNAL ARTICLE COLLECTION CONTINUES TO GROW AS NEW RESEARCH IN VARIOUS FIELDS BREAKS TO THE SURFACE. MORE THAN 10,000 ARTICLES HAVE BEEN COLLECTED FROM SOURCES OUTSIDE OUR LIBRARY. AS A RESEARCH LIBRARY, YOU'RE WELCOME TO UTILIZE OUR COLLECTION SOLEY ON SITE. SUPPLEMENT YOUR RESEARCH AND FINDINGS WITH INTERNET ACCESS. THE MAYBEE LIBRARY WILL CONTINUE TO BE CUTTING EDGE BASED ON PRIVATE DONATIONS FROM INDIVIDUALS, CORPORATIONS, AND FOUNDATIONS. SINCE CO-LEARNERS ARE ENCOURAGED TO SEEK OUT INFORMATION ABOUT THEIR INDIVIDUAL NEEDS, THE RIORDAN RESOURCE LIBRARY PLAYS A SIGNIFICANT ROLE IN THAT PROCESS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S 990 IS REVIEWED BY A MEMBER OF THE BOARD, THE CHIEF EXECUTIVE OFFICER AND CHIEF OPERATING OFFICER PRIOR TO FILING WITH THE INTERNAL REVENUE SERVICE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION HAS A CONFLICT OF INTEREST POLICY. ALL OFFICERS AND KEY EMPLOYEES ARE AWARE OF THE POLICY AND ANY POTENTIAL CONFLICTS ARE ADDRESSED THROUGHOUT THE YEAR.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>OFFICERS AND KEY EMPLOYEE COMPENSATION IS REVIEWED BY THE ORGANIZATION'S BOARD ON AN ANNUAL BASIS. SALARY RANGES ARE APPROVED FOR VARIOUS STAFF POSITIONS BY THE BOARD AS WELL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATIONS OFFICERS AND KEY EMPLOYEE COMPENSATION IS REVIEWED BY THE ORGANIZATION'S BOARD ON AN ANNUAL BASIS. SALARY RANGES ARE APPROVED FOR VARIOUS STAFF POSITIONS BY THE BOARD AS WELL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION MAKES THESE ITEMS AVAILABLE TO THE PUBLIC UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>